Racetams

Brivaracetam

Products Brivaracetam was approved in the EU, the United States, and many countries in 2016 in the form of film-coated tablets, oral solution, and solution for injection (Briviact). Structure and properties Brivaracetam (C11H20N2O2, Mr = 212.3 g/mol) is structurally and pharmacologically closely related to levetiracetam (Keppra, generics). Like levetiracetam, it is a pyrrolidinone derivative. Effects … Brivaracetam

Levetiracetam

Products Levetiracetam is commercially available as film-coated tablets, an oral solution, and an infusion concentrate (Keppra, generics). It has been approved in many countries since 2000 (United States: 1999). Starting in 2011, generics and new dosage forms entered the market (minipacks). Brivaracetam (Briviact) was developed by UCB as its successor. Structure and properties Levetiracetam (C8H14N2O2, … Levetiracetam